The Global Drug Policy Index (GDPI) is a unique accountability tool that documents, measures and compares national-level drug policies. It provides each country with a score from 0 to 100, where 100 represents full alignment of a selected core of drug policies and their implementation with the United Nations recommendations on human rights, health and development, as laid down in the UN System Common Position on drugs. The first iteration of the Global Drug Policy Index was released in November 2021, and it evaluates the performance of 30 countries covering all regions of the world, for the year 2020.

The Global Drug Policy Index provides each country with a score and ranking that shows how much their drug policies and their implementation align with the UN principles of human rights, health and development. It offers an essential accountability and evaluation mechanism in the field of drug policy. The Index is composed of 75 indicators running across 5 broad dimensions of drug policy: the absence of extreme responses, the proportionality of the criminal justice response, health and harm reduction, access to controlled medicines and development.

The Global Drug Policy Index is a project of the Harm Reduction Consortium, a global partnership of civil society and community networks aiming to challenge the global ‘war on drugs’, which also includes the Global Drug Policy Observatory at Swansea University.

See the full Global Drug Policy Index: https://globaldrugpolicyindex.net/